Comprehensive Frailty Assessment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 111
- 试验地点
- 1
- 主要终点
- Change in Comprehensive Frailty Assessment
研究概览
简要总结
The purpose of this research study is to describe a patients' fitness before and after treatment (whether that treatment be chemotherapy or a transplant). Fitness is a way of measuring a patient's current quality of health. With surveys, questionnaires and blood tests, we hope to create a tool that will give a good picture of patients' ability to tolerate treatment. In the future, we hope to devise the best treatment for a patient based on their "fitness".
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients with a plasma cell dyscrasia AND/OR any patient receiving a stem cell transplant for a hematologic malignancy at The Ohio State University
- •at least 18 years of age
排除标准
- •Any medical or psychiatric condition that would make it difficult for the patient to comply with study procedures.
结局指标
主要结局
Change in Comprehensive Frailty Assessment
时间窗: up to 14 months
Responses to the Comprehensive Frailty Assessment will be assessed before and after treatment and changes will be evaluated. In transplant patients, this will be measured one year post transplant and in the non-transplant arm, this will be assessed after the second cycle of treatment.
次要结局
- Time to progression(date of enrollment to date of documented clinical progression up to two years post-enrollment)
研究者
Ashley Rosko
Principal Investigator
Ohio State University Comprehensive Cancer Center